CD4 and colorectal carcinoma: One of the first studies in CRC patients showed that peripheral blood derived CD4+CD25+ T cell lines inhibited via TGF-β cytotoxicity and proliferation of autologous HLA-A1 restricted CD4+ CTLs [106].